|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2008-6-26
|
|
pubmed:abstractText |
Cartilage destruction in osteoarthritis (OA) involves excessive degradation and increased synthesis of cartilage matrix macromolecules including type II collagen and proteoglycans. Cartilage biomarkers exist for the measurement of cartilage matrix turnover and may reveal differences in patients with OA.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0392-856X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
26
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
430-5
|
|
pubmed:dateRevised |
2010-3-23
|
|
pubmed:meshHeading |
pubmed-meshheading:18578964-Adult,
pubmed-meshheading:18578964-Aged,
pubmed-meshheading:18578964-Aged, 80 and over,
pubmed-meshheading:18578964-Aggrecans,
pubmed-meshheading:18578964-Biological Markers,
pubmed-meshheading:18578964-Calcium-Binding Proteins,
pubmed-meshheading:18578964-Cartilage, Articular,
pubmed-meshheading:18578964-Collagen Type II,
pubmed-meshheading:18578964-Cross-Sectional Studies,
pubmed-meshheading:18578964-Female,
pubmed-meshheading:18578964-Humans,
pubmed-meshheading:18578964-Logistic Models,
pubmed-meshheading:18578964-Male,
pubmed-meshheading:18578964-Middle Aged,
pubmed-meshheading:18578964-Osteoarthritis,
pubmed-meshheading:18578964-Osteoarthritis, Hip,
pubmed-meshheading:18578964-Proteoglycans
|
|
pubmed:articleTitle |
Serum concentrations of type II collagen biomarkers (C2C, C1, 2C and CPII) suggest different pathophysiologies in patients with hip osteoarthritis.
|
|
pubmed:affiliation |
Department of Rheumatology, University Hospital Lyon-Sud , Lyon, France. thierry.conrozier@chu-lyon.fr
|
|
pubmed:publicationType |
Journal Article,
Comparative Study
|
